Click here to browse the full category:

Blood Diseases research reports

Blood Diseases Research Reports


Erythropoiesis-Stimulating Agents in the Treatment of Chemotherapy Induced Anemia and Anemia in Chronic Kidney Disease in the US
Topics: Blood Diseases, Research & Development, Oncology/Hematology
Regions: United States
Hemophilia Global Clinical Trials Review, Q1, 2011
Topics: Blood Diseases, Clinical Trial
Hemophilia A Global Clinical Trials Review, Q1, 2011
Topics: Blood Diseases, Clinical Trial
Hemophilia B Global Clinical Trials Review, Q1, 2011
Topics: Blood Diseases, Drug Discovery, Clinical Trial
Iron Deficiency Anemia - Pipeline Review, Q2 2011
Topics: Blood Diseases, Dietary Supplements, Drug Discovery
Chemotherapy Induced Anemia - Pipeline Review, Q1 2011
Topics: Blood Diseases
Myelodysplastic Syndrome Therapy Area Pipeline Report
Topics: Blood Diseases
Thrombocytopenia and Idiopathic Thrombocytopenic Purpura Therapy Area Pipeline Report
Topics: Blood Diseases
Hemophilia - Pipeline Review, Q1 2011
Topics: Blood Diseases, Drug Discovery
Anemia Therapy Area Pipeline Report
Topics: Blood Diseases
Haemophilia and Blood Coagulation Disorders Therapy Area Pipeline Report
Topics: Blood Diseases
Hemorrhage Therapy Area Pipeline Report
Topics: Blood Diseases
Hemophilia A - Pipeline Review, Q1 2011
Topics: Blood Diseases, Drug Discovery
Anemia Global Clinical Trials Review, Q1, 2011
Topics: Blood Diseases, Drug Discovery
Anemia Therapy Pipeline Report
Topics: Blood Diseases, Drug Discovery
Haemophilia and Blood Coagulation Disorders Therapy Pipeline Report
Topics: Blood Diseases, Drug Discovery
Iron Deficiency Anemia - Pipeline Review, Q4 2010
Topics: Blood Diseases
Anemia - Pipeline Review, Q4 2010
Topics: Blood Diseases
Hemophilia - Pipeline Review, Q4 2010
Topics: Blood Diseases
Hemophilia A - Pipeline Review, Q4 2010
Topics: Blood Diseases, Drug Discovery
Hemophilia B - Pipeline Review, Q4 2010
Topics: Blood Diseases, Drug Discovery
Failure of TAK442 to Meet the Primary End-point in a Phase II Study Underlines the Challenging Clinical Development Environment for Anticoagulants in Acute Coronary Syndromes
Topics: Blood Diseases, Coagulation, Cardiovascular
Intravenous (IV) Iron Drugs
Topics: Blood Diseases, Needles, Syringes, IV Access
Regions: Global
Stakeholder Opinions: Hemophilia - The harsh reality of commercialising a great research opportunity?
Topics: Blood Diseases, Drug Discovery
Pipeline Insight: Lymphomas, Multiple Myeloma & Myelodysplastic Syndromes - Optimization of clinical practice creates opportunities for emerging therapies
Topics: Stem Cell, Blood Diseases, Research & Development, Drug Discovery, Oncology/Hematology
Anemia Drugs
Topics: Blood Diseases, Research & Development, Prescription Drugs, Drug Discovery
Regions: Global
The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 - Better and More Cost-Effective Treatment Options Create Opportunities
Topics: Blood Diseases
Myelodysplastic Syndromes (High-Risk)
Topics: Biomarkers, Blood Diseases, Drug Delivery, Drug Discovery
Blood and Lymphatic System Dyslipidemia Therapy Area Pipeline Report
Topics: Blood Diseases, Drug Discovery, Cardiovascular
Blood and Lymphatic System Electrolyte Deficiencies Therapy Area Pipeline Report
Topics: Blood Diseases, Drug Discovery
Blood and Lymphatic System Hemophilia or Blood Coagulation Disorders Therapy Area Pipeline Report
Topics: Blood Diseases, Drug Discovery
Blood and Lymphatic System Hyperlipemia Therapy Area Pipeline Report
Topics: Blood Diseases, Drug Discovery
Blood and Lymphatic System Myelodysplastic Syndrome Therapy Area Pipeline Report
Topics: Blood Diseases, Drug Discovery
Blood and Lymphatic System Thrombocytopenia or Idiopathic Thrombocytopenic Purpura Therapy Area Pipeline Report
Topics: Blood Diseases, Drug Discovery
Blood and Lymphatic System Anemia Therapy Area Pipeline Report
Topics: Blood Diseases, Drug Discovery
Blood and Lymphatic System Hemorrhage Therapy Area Pipeline Report
Topics: Blood Diseases, Drug Discovery
Blood and Lymphatic System Thromboembolism Therapy Area Pipeline Report
Topics: Blood Diseases, Drug Discovery
The 2010-2015 World Outlook for Anticoagulants
Topics: In Vitro Diagnostics, Blood Diseases, Prescription Drugs, Cardiovascular
Regions: Global
The 2010-2015 Outlook for Anticoagulants
Topics: Blood Diseases, Prescription Drugs
The 2010-2015 Outlook for Anticoagulants in India
Topics: Blood Diseases
Regions: India
Chinese Markets for Blood Disease Drugs
Topics: Blood Diseases
Regions: China
The 2009 Report on Anticoagulant Pharmaceutical Preparations: World Market Segmentation by City
Topics: Blood Diseases, Manufacturing, Packaging & Detailing
The 2009-2014 World Outlook for Anticoagulant Pharmaceutical Preparations
Topics: Blood Diseases, Manufacturing, Packaging & Detailing
Regions: Global
How Have Safety Concerns and New Warnings Affected the Anemia Market?
Topics: Blood Diseases, Oncology/Hematology, Renal
Blood Cancer Drug Discoveries: what the future holds
Topics: Blood Diseases, Research & Development, Oncology/Hematology
The World Cardiovascular Drug Market, (Antihypertensives, Antihyperlipidemics, Vasodilators, Anticoagulants, Diuretics and other Agents)
Topics: Blood Diseases, Hypertension, Prescription Drugs, Drug Discovery, Cardiovascular
Regions: Global
Blood Disorder Treatments
Topics: Blood Diseases, Oncology/Hematology
Global Pipeline Review & Analysis of Hematological Malignancies
Topics: Blood Diseases, Oncology/Hematology
The Anemia Market: Biogenerics and Second-Generation Products Drive Change
Topics: Proteomics, Blood Diseases, Biotechnology
The 2007-2012 Outlook for Anticoagulant Pharmaceutical Preparations in the United States
Topics: Blood Diseases, Manufacturing, Packaging & Detailing


Prev  | 1  | 2  | 3  | Next    

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.